Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5924)
All Articles published online
|
Publishing Process of This Article
|
Nov 10, 2012 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Valle RD, Cerio ALD, Inoges S, Tejada S, Pastor F, Villanueva H, Gallego J, Espinos J, Aristu J, Idoate MA, Andreu E, Bendandi M. Dendritic cell vaccination in glioblastoma after fluorescence-guided resection. World J Clin Oncol 2012; 3(11): 142-149 [PMID: 23293753 DOI: 10.5306/wjco.v3.i11.142] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v3/i11/142.htm |
| Number | Citing Articles |
| 1 |
Amy E. Schmidt, Majed A. Refaai, Neil Blumberg. Past, present and forecast of transfusion medicine: What has changed and what is expected to change?. La Presse Médicale 2016; 45(7-8): e253 doi: 10.1016/j.lpm.2016.06.017
|
| 2 |
Susana Inogés, Sonia Tejada, Ascensión López-Díaz de Cerio, Jaime Gállego Pérez-Larraya, Jaime Espinós, Miguel Angel Idoate, Pablo Daniel Domínguez, Reyes García de Eulate, Javier Aristu, Maurizio Bendandi, Fernando Pastor, Marta Alonso, Enrique Andreu, Felipe Prósper Cardoso, Ricardo Díez Valle. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients. Journal of Translational Medicine 2017; 15(1) doi: 10.1186/s12967-017-1202-z
|
| 3 |
Lien Vandenberk, Jochen Belmans, Matthias Van Woensel, Matteo Riva, Stefaan W. Van Gool. Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines. Frontiers in Immunology 2016; 6 doi: 10.3389/fimmu.2015.00663
|
| 4 |
Marion Rapp, Oliver M. Grauer, Marcel Kamp, Natalie Sevens, Nikola Zotz, Michael Sabel, Rüdiger V. Sorg. A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial. Trials 2018; 19(1) doi: 10.1186/s13063-018-2659-7
|
| 5 |
Nataša Tešić, Iza Pekle Simonič, Katja Roškar, Primož Rožman, Urban Švajger. Dendritic Cells Generated in the Presence of Platelet Lysate Have a Reduced Type 1 Polarization Capacity. Immunological Investigations 2020; 49(3): 215 doi: 10.1080/08820139.2019.1624768
|
| 6 |
Stefaan W. Van Gool, Peter Van de Vliet, Linde F.C. Kampers, Jennifer Kosmal, Tobias Sprenger, Ella Reich, Volker Schirrmacher, Wilfried Stuecker. Cell-based Cancer Immunotherapy. Methods in Cell Biology 2024; 183: 51 doi: 10.1016/bs.mcb.2023.06.001
|
| 7 |
Xiguo Liu, Junjing Yang, Wankai Deng. The inflammatory cytokine IL-22 promotes murine gliomas via proliferation. Experimental and Therapeutic Medicine 2017; 13(3): 1087 doi: 10.3892/etm.2017.4059
|
| 8 |
Nasser K. Yaghi, Mark R. Gilbert. Immunotherapeutic Approaches for Glioblastoma Treatment. Biomedicines 2022; 10(2): 427 doi: 10.3390/biomedicines10020427
|
| 9 |
Sébastien Anguille, Evelien L Smits, Eva Lion, Viggo F van Tendeloo, Zwi N Berneman. Clinical use of dendritic cells for cancer therapy. The Lancet Oncology 2014; 15(7): e257 doi: 10.1016/S1470-2045(13)70585-0
|
| 10 |
Farhad Dastmalchi, Aida Karachi, Duane Mitchell, Maryam Rahman. Encyclopedia of Life Sciences. 2018; : 1 doi: 10.1002/9780470015902.a0024243
|
| 11 |
Oliver D. Mowforth, Jamie Brannigan, Marc El Khoury, Celine Iswarya Partha Sarathi, Harry Bestwick, Faheem Bhatti, Richard Mair. Personalised therapeutic approaches to glioblastoma: A systematic review. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1166104
|
| 12 |
David C. Binder, Andrew A. Davis, Derek A. Wainwright. Immunotherapy for cancer in the central nervous system: Current and future directions. OncoImmunology 2016; 5(2): e1082027 doi: 10.1080/2162402X.2015.1082027
|
| 13 |
Edoardo Agosti, Marco Zeppieri, Lucio De Maria, Camilla Tedeschi, Marco Maria Fontanella, Pier Paolo Panciani, Tamara Ius. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements. International Journal of Molecular Sciences 2023; 24(20): 15037 doi: 10.3390/ijms242015037
|
| 14 |
Stefaan W. Van Gool, Jennifer Makalowski, Simon Fiore, Tobias Sprenger, Lothar Prix, Volker Schirrmacher, Wilfried Stuecker. Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged. Cancers 2020; 13(1): 32 doi: 10.3390/cancers13010032
|
| 15 |
Boyuan Huang, Hongbo Zhang, Lijuan Gu, Bainxin Ye, Zhihong Jian, Creed Stary, Xiaoxing Xiong. Advances in Immunotherapy for Glioblastoma Multiforme. Journal of Immunology Research 2017; 2017: 1 doi: 10.1155/2017/3597613
|
| 16 |
Lien Vandenberk, Abhishek D. Garg, Tina Verschuere, Carolien Koks, Jochen Belmans, Monique Beullens, Patrizia Agostinis, Steven De Vleeschouwer, Stefaan W. Van Gool. Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. OncoImmunology 2016; 5(2): e1083669 doi: 10.1080/2162402X.2015.1083669
|
| 17 |
Angeliki Datsi, Rüdiger V. Sorg. Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.770390
|